196 related articles for article (PubMed ID: 15217571)
1. [Update on medical treatment of female stress urinary incontinence].
Yazbeck C; Dhainaut C; Batallan A; Thoury A; Madelenat P
Gynecol Obstet Fertil; 2004 Jun; 32(6):556-61. PubMed ID: 15217571
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
Puyol M; Collado A
Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for stress urinary incontinence.
Castro-Diaz D; Amoros MA
Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
[TBL] [Abstract][Full Text] [Related]
4. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
Thor KB
Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
[TBL] [Abstract][Full Text] [Related]
6. [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].
MMW Fortschr Med; 2004 Feb; 146(7):59. PubMed ID: 15347056
[No Abstract] [Full Text] [Related]
7. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
9. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.
Fraser MO; Chancellor MB
BJU Int; 2003 May; 91(8):743-8. PubMed ID: 12709086
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
11. Stress incontinence: help at hand.
Wyllie MG
BJU Int; 2004 May; 93(7):1105-6. PubMed ID: 15142172
[No Abstract] [Full Text] [Related]
12. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
Cardozo L
J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
Zinner NR
Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
[TBL] [Abstract][Full Text] [Related]
15. Mixed incontinence.
Wein AJ
J Urol; 2005 Jun; 173(6):2055-7. PubMed ID: 15879826
[No Abstract] [Full Text] [Related]
16. [Pharmacotherapy of stress incontinence].
Jost WH; Marsalek P; Michel MC
Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women.
Thor KB; Donatucci C
J Urol; 2004 Jul; 172(1):27-33. PubMed ID: 15201731
[TBL] [Abstract][Full Text] [Related]
18. [A challenge].
Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
[No Abstract] [Full Text] [Related]
19. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
20. [New options in pharmacological treatment of urinary stress incontinence in women].
Martan A
Ceska Gynekol; 2004 Nov; 69(6):500-6. PubMed ID: 15633423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
